Pancreatic cancer: does it matter when chemotherapy starts?

LW Newsfeed
Time to chemotherapy initiation is not significantly associated with long-term survival of patients with resected pancreatic cancer.

11,098 patients with pancreatic cancer — 6706 who underwent resection alone, 3723 who initiated adjuvant chemotherapy at ≤12 wk, and 669 who initiated adjuvant chemotherapy at 12 wk — were analyzed for survival outcomes. Read more . . .

image_printPrint Page

Conversation